Forms Comparison
| Form | Bioavailability | Best For |
|---|---|---|
| MK-7 (Menaquinone-7) | High | Daily supplementation — long half-life (72 hours), consistent blood levels with once-daily dosing; derived from natto fermentation |
| MK-4 (Menatetrenone) | Moderate | High-dose therapeutic use — short half-life (1-2 hours), requires multiple daily doses; used at 45 mg/day in Japanese osteoporosis treatment |
| Full-Spectrum K2 (MK-4 + MK-7) | High | Comprehensive approach — combines short-acting tissue distribution (MK-4) with long-acting systemic effects (MK-7) |